| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,831 | 15,031 | 12,650 | 18,267 | | Cost of Revenue | (18,835) | 18,835 |
-
|
-
| | | Gross Profit | 31,666 | (3,804) | 12,650 | 18,267 | | | Operating Expenses | | Research Development | 1,350 | (761) | 761 |
-
| | Selling General and Administrative | 5,089 | (1,443) | 13,430 | 12,659 | | Non Recurring | 25,780 |
-
|
-
| 4,949 | | Others | 3,370 | (1,065) | 1,065 | 2,312 | | | | Total Operating Expenses | 35,589 |
-
|
-
|
-
| | | | Operating Income or Loss | (3,923) | (535) | (2,606) | (1,653) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 224 | 47 | 287 | (115) | | Earnings Before Interest And Taxes | (3,699) | (488) | (2,319) | (1,768) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,699) | (488) | (2,319) | (1,768) | | Income Tax Expense | 47 | 39 | 38 | 39 | | Minority Interest | (3,150) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,896) | (527) | (2,357) | (1,807) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (6,896) | (527) | (2,357) | (1,807) | | Preferred Stock And Other Adjustments | 2,121 | (2,121) |
-
|
-
| | | Net Income Applicable To Common Shares | ($4,775) | ($2,648) | ($2,357) | ($1,807) |
|
0.31% Nasdaq 
0.05%
Income Statement
